Dibucaine: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 1: Line 1:
{{DrugProjectFormSinglePage
{{DrugProjectFormSinglePage
|authorTag={{RB}}  
|authorTag={{RB}}
|OTC=Yes
|OTC=Yes
|genericName=Dibucaine
|genericName=Dibucaine
|aOrAn=a
|aOrAn=a
|drugClass=Local analgesic ointment  
|drugClass=Local analgesic ointment
|indicationType=treatment
|indicationType=treatment
|indication=pain and itching due to hemorrhoids or other anorectal disorders, sunburn, minor burns, minor cuts  
|indication=pain and itching due to hemorrhoids or other anorectal disorders, sunburn, minor burns, minor cuts
|adverseReactions=unusual warmth or flushing of skin
|adverseReactions=unusual warmth or flushing of skin


Line 30: Line 30:
- gently dry by patting or blotting with toilet tissue or a soft cloth before applying  
- gently dry by patting or blotting with toilet tissue or a soft cloth before applying  


Adults and children 12 and over - apply externally to the affected area up to 3 to 4 times a day.  
Adults and children 12 and over - apply externally to the affected area up to 3 to 4 times a day.
 
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


Line 49: Line 48:


<!--Contraindications-->
<!--Contraindications-->
|contraindications=
|contraindications=<!--Warnings-->
 
<!--Warnings-->
|warnings=* For external use only.  
|warnings=* For external use only.  


Line 74: Line 71:


<!--Clinical Trials Experience-->
<!--Clinical Trials Experience-->
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
|clinicalTrials=There is limited information regarding <i>clinical trial experience</i> of {{PAGENAME}} in the drug label.
 
|postmarketing=unusual warmth or flushing of skin
=====Body as a Whole=====
Chest pain
 
fast or irregular heartbeat
 
tightness in the chest
 
|drugInteractions=
 
=====Cardiovascular=====
 
 
 
 
=====Digestive=====
 
 
 
 
=====Endocrine=====
 
 
 
 
=====Hematologic and Lymphatic=====
 
 
 
 
=====Metabolic and Nutritional=====
 
 
 
 
=====Musculoskeletal=====
 
 
 
 
=====Neurologic=====
 
 
 
 
=====Respiratory=====
 
 
 
 
=====Skin and Hypersensitivy Reactions=====
 
 
 
 
=====Special Senses=====
 
 
 
 
=====Urogenital=====
 
 
 
 
=====Miscellaneous=====
 
 
 
<!--Postmarketing Experience-->
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
 
=====Body as a Whole=====
 
 
 
=====Cardiovascular=====
 
 
 
=====Digestive=====
 
 
 
=====Endocrine=====
 
 
 
=====Hematologic and Lymphatic=====
 
 
 
=====Metabolic and Nutritional=====
 
 
 
=====Musculoskeletal=====
 
 
 
=====Neurologic=====
 
 
 
=====Respiratory=====
 
 
 
=====Skin and Hypersensitivy Reactions=====
 
 
 
=====Special Senses=====
 
 
 
=====Urogenital=====
 
 
 
=====Miscellaneous=====
 
 
 
<!--Drug Interactions-->
|drugInteractions=* Drug
:* Description


<!--Use in Specific Populations-->
<!--Use in Specific Populations-->
|useInPregnancyFDA=* If pregnant or breast feeding, as a health care professional before use  
|useInPregnancyFDA=* If pregnant or breast feeding, as a health care professional before use
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''


There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
|useInNursing=* If pregnant or breast feeding, as a health care professional before use  
|useInNursing=* If pregnant or breast feeding, as a health care professional before use
|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
Line 225: Line 104:


<!--Overdosage-->
<!--Overdosage-->
|overdose=Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away  
|overdose=Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away
|drugBox=<!--Mechanism of Action-->
|drugBox=<!--Mechanism of Action-->
|mechAction=*  
|mechAction=*  


<!--Structure-->
<!--Structure-->
|structure=*  
|structure=* Active ingredients - Dibucaine 1%
Inactive Ingredients
 
acetone sodium bisulfite, lanolin, light mineral oil, purified water, white petrolatum


: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]


<!--Pharmacodynamics-->
<!--Pharmacodynamics-->
Line 248: Line 129:
<!--How Supplied-->
<!--How Supplied-->
|howSupplied=*
|howSupplied=*
|packLabel=<!--Patient Counseling Information-->
|storage=store at controlled room temperature 20 degrees to 25 degrees c
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
|packLabel=====Ingredients and Appearance====
: [[File:Dibucaine Ing and App.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
 


<!--Precautions with Alcohol-->
 
<!--Patient Counseling Information-->
|fdaPatientInfo=to secure child resistant cap; screw cap tightly. Then turn cap in opposite direction.
If clicking sound is not heard, repeat procedure.
- see crimp of tube for lot number and expiration date
|alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
|alcohol=* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.


<!--Brand Names-->
<!--Brand Names-->
|brandNames=* ®<ref>{{Cite web | title =  | url = }}</ref>
|brandNames=* DIBUCAINE®<ref>{{Cite web | title = Dibucaine | url =http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e3807a1b-c375-456a-bd7e-de3a1607c8fc }}</ref>


<!--Look-Alike Drug Names-->
<!--Look-Alike Drug Names-->
|lookAlike=* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
|lookAlike=There is limited information regarding the look alike names.
 
<!--Drug Shortage Status-->
|drugShortage=
|drugShortage=
}}
}}

Revision as of 10:38, 17 April 2015

Dibucaine
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rabin Bista, M.B.B.S. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Overview

Dibucaine is a Local analgesic ointment that is FDA approved for the treatment of pain and itching due to hemorrhoids or other anorectal disorders, sunburn, minor burns, minor cuts. Common adverse reactions include unusual warmth or flushing of skin.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications

temporarily relieves pain and itching due to:

- hemorrhoids or other anorectal disorders - sunburn - minor burns - minor cuts - scrapes - insect bites - minor skin irritation

Dosage

Directions

- if possible clean the affected area with mild soap and warm water and rinse thoroughly - gently dry by patting or blotting with toilet tissue or a soft cloth before applying

Adults and children 12 and over - apply externally to the affected area up to 3 to 4 times a day.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Dibucaine in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Dibucaine in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Children under 2 - 12 years of age - ask a doctor

Infants under 2 years of age - DO NOT USE

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Dibucaine in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Dibucaine in pediatric patients.

Contraindications

There is limited information regarding Dibucaine Contraindications in the drug label.

Warnings

  • For external use only.

Allergy alert - certain persons san develop allergic reactions to ingredients in this product

Do not use - in or near the eyes - do not get into the eyes - in infants under 2 years of age - in large quantities, particularly over raw surfaces or blistered areas - do not put this product into rectum by using fingers or any mechanical device

Stop use and ask a doctor if - condition worsens, or does not improve within 7 days - the symptom being treated does not subside or if redness, irritation, swelling, bleeding or other symptoms develop or increase

If pregnant or breast feeding, as a health care professional before use

Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away

Adverse Reactions

Clinical Trials Experience

There is limited information regarding clinical trial experience of Dibucaine in the drug label.

Postmarketing Experience

unusual warmth or flushing of skin Chest pain fast or irregular heartbeat tightness in the chest

Drug Interactions

There is limited information regarding Dibucaine Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • If pregnant or breast feeding, as a health care professional before use


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Dibucaine in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Dibucaine during labor and delivery.

Nursing Mothers

  • If pregnant or breast feeding, as a health care professional before use

Pediatric Use

There is no FDA guidance on the use of Dibucaine with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Dibucaine with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Dibucaine with respect to specific gender populations.

Race

There is no FDA guidance on the use of Dibucaine with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Dibucaine in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Dibucaine in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Dibucaine in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Dibucaine in patients who are immunocompromised.

Administration and Monitoring

Administration

  • topical

Monitoring

There is limited information regarding Monitoring of Dibucaine in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Dibucaine in the drug label.

Overdosage

Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away

Pharmacology

There is limited information regarding Dibucaine Pharmacology in the drug label.

Mechanism of Action

Structure

  • Active ingredients - Dibucaine 1%

Inactive Ingredients

acetone sodium bisulfite, lanolin, light mineral oil, purified water, white petrolatum

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Dibucaine in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Dibucaine in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Dibucaine in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Dibucaine in the drug label.

How Supplied

Storage

store at controlled room temperature 20 degrees to 25 degrees c

Images

Drug Images

{{#ask: Page Name::Dibucaine |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

Ingredients and Appearance

This image is provided by the National Library of Medicine.

{{#ask: Label Page::Dibucaine |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

to secure child resistant cap; screw cap tightly. Then turn cap in opposite direction. If clicking sound is not heard, repeat procedure. - see crimp of tube for lot number and expiration date

Precautions with Alcohol

  • Alcohol-Dibucaine interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Look-Alike Drug Names

There is limited information regarding the look alike names.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ "Dibucaine".

{{#subobject: 

 |Page Name=Dibucaine
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject: 

 |Label Page=Dibucaine
 |Label Name=Dibucaine11.png

}}

{{#subobject: 

 |Label Page=Dibucaine
 |Label Name=Dibucaine11.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Dibucaine&oldid=1088594"